| Trial Identifier: | D5160C00035 |
| Sponsor: | AstraZeneca |
| Collaborator: |
Quintiles
|
| NCTID:: | NCT02923947 |
| Start Date: | May 2017 |
| Primary Completion Date: | September 2018 |
| Study Completion Date: | October 2022 |
| Condition: | Cancer - Other |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Translation | |
| French Translation | |
| Korean Translation | |
| Spanish Translation |
| Country | Location |
|---|---|
| ES | Madrid, ES, 28050 |
| ES | Madrid, ES, 28040 |
| ES | Madrid, ES, 28046 |
| ES | Sevilla, ES, 41013 |
| FR | Angers Cedex 2, FR, 49055 |
| FR | Bordeaux, FR, 33000 |
| FR | Dijon, FR, 21079 |
| FR | Lille Cedex, FR, 59020 |
| FR | Saint Herblain, FR, 44805 |
| KR | Seoul, KR, 03080 |
| KR | Seoul, KR, 05505 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company